uniQure Announces Presentations at Upcoming April Conferences
(Thomson Reuters ONE) -
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, April 03, 2017 (GLOBE NEWSWIRE)
-- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing
transformative therapies for patients with severe medical needs, today announced
presentations at the following conferences taking place in April:
World Orphan Drug Congress USA, April 19 - 21 2017, at the Washington Marriott
Wardman Park in Washington D.C.
* Matt Kapusta, Chief Executive Officer, will be presenting a keynote address:
Adeno-associated virus (AAV)-based gene therapies for rare, chronic and
degenerative diseases, on Friday April 21st, 2017, 9.40 a.m. EDT.
12th Annual HD Therapeutics Conference by CHDI, April 24 - 27 2017, at the
Westin Dragonara Resort in St. Julian's, Malta.
* A presentation new preclinical data on huntingtin gene silencing in a mini-
pig model of Huntington's Disease, using allele-specific and non-selective
miRNAs, will be presented during the CHDI conference.
Gene Therapy for Rare Disorders Conference, April 25 - 26 2017, at the Sheraton
Boston Hotel, in Boston MA.
* Lance Weed, Vice President of US Operations, will be presenting: Optimizing
the Scalability of Gene Therapy Manufacturing, on Tuesday April
25th, 2017, 2.00 p.m. EDT.
* Eileen Sawyer, Director of Global Medical Affairs, will be presenting:
Bridging Gaps Through Early Integration of the Internal Medical Affairs
Function, on Wednesday April 26th, 2017, 11.00 a.m. EDT.
* Daniel Leonard, Director of Global Patient Advocacy, will be presenting: The
Intersection of Patient Advocacy and Gene Therapy: A Case Study in
Hemophilia, on Wednesday April 26th, 2017, 2.00 p.m. EDT.
Alliance for Regenerative Medicines (ARM)'s 5th Annual Cell & Gene Therapy
Investor Day, April 27th 2017, at The State Room, in Boston MA.
* Matthew Kapusta, chief executive officer, will be participating in a
fireside chat on Thursday, April 27th, 2017, 2.15 p.m. EDT.
The Company also announced its participation in the following conferences taking
place in April:
Hemophilia Federation of America (HFA)'s Annual Symposium, April 6 - 9 2017, at
the Rhode Island Convention Center in Providence, RI.
The International Liver Congress 2017 by EASL, April 19 - 23 2017 at the RAI in
Amsterdam, The Netherlands.
About uniQure
uniQure is delivering on the promise of gene therapy - single treatments with
potentially curative results. We are leveraging our modular and validated
technology platform to rapidly advance a pipeline of proprietary and partnered
gene therapies to treat patients with hemophilia, Huntington's disease and
cardiovascular diseases. www.uniQure.com
uniQure Contacts:
Maria E. Cantor
Direct: 339-970-7536
Mobile: 617-680-9452
m.cantor(at)uniQure.com
Eva M. Mulder
Direct: +31 20 240 6103
Mobile: +31 6 52 33 15 79
e.mulder(at)uniQure.com
Tom Malone
Direct: 339-970-7558
Mobile: 339-223-8541
t.malone(at)uniQure.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: uniQure N.V. via GlobeNewswire
Datum: 04.04.2017 - 20:33 Uhr
Sprache: Deutsch
News-ID 534515
Anzahl Zeichen: 3815
contact information:
Town:
Amsterdam
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 137 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"uniQure Announces Presentations at Upcoming April Conferences"
steht unter der journalistisch-redaktionellen Verantwortung von
uniQure N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
